Life-Saving Heart Surgeries Give Four Kyrgyz Children a Fresh Start in South Korea
A seven-month-old infant who faced a life-threatening crisis without urgent intervention by the end of the year has successfully recovered following...
Search results for "patient"
Depressive Symptoms Linked to Higher Fatty Liver Risk in Young Adults
Young adults in South Korea who experience depressive symptoms face roughly twice the risk of developing fatty liver disease, with the risk...
Asan Medical Center Performs South Korea’s First Artisse Implant to Seal Complex Brain Aneurysms
Treating a brain aneurysm presents steep clinical challenges when the lesion features a wide neck or develops at a...
'A Hellish Time': Chronic Ear Disorder Forces IU to Postpone Concert Tour and Album Release
Singer and actor IU, 33, has postponed her upcoming September concert tour and the release of her sixth full-length...
Novartis Halts Lu-NeoB Development After Early Clinical Data Fall Short
Novartis has discontinued the development of Lu-NeoB, an experimental cancer therapy designed to seek out tumor cells...
Blood Sugar Control After Stomach Cancer Surgery Varies Sharply by Intestinal Reconstruction Method
For patients navigating both stomach cancer and type 2 diabetes, the surgical method used to reconnect the digestive...
50 Years After Its Discovery, Legionnaires’ Disease Remains a Summer Threat as Cooling Systems Hum
As sweltering heat waves and high humidity force air conditioners and cooling equipment to run continuously, public...
"1 Million Won a Month Covers Everything"? The Hidden Cost Trap in Long-Term Senior Care
"If you pay in the 1 million won-a-month range, we’ll take care of everything." It is a familiar sales pitch at many...
Placebo Outperforms TG-C: Data Errors and Stock Volatility Cloud Kolon TissueGene’s Phase 3 Trial
Kolon TissueGene’s knee osteoarthritis cell and gene therapy, TG-C, has failed to achieve statistical significance on...
Lilly’s Retatrutide Cuts Weight by 22.6% in Phase 3 Trials, But Cardiovascular Protection Remains Unproven
Eli Lilly and Company’s next-generation obesity treatment, retatrutide, reduced body weight by up to 22.